October 2022: Neuro-Pharmacological Study of Posaconazole for Glioblastoma: A Phase 0 Clinical Trial Protocol - Congress of Neurological Surgeons (CNS)

Log In Create an Account

Residents Foundation Directory

Join CNS

Publications /

Neurosurgery Publications Overvie... /

Journal Club Podcasts /

October 2022: Neuro-Pharmacological Study of Posac...
October 2022: Neuro-Pharmacological Study of Posaconazole for Glioblastoma: A Phase 0 Clinical Trial Protocol
Posted : Sep 15, 2022
Congress of Neurological Surgeons Podcasts · Neuro-Pharmacological Study of Posaconazole for Glioblastoma: A Phase 0 Clinical Trial Protocol
October 2022

Length: 17:18 min.

To establish brain tumor penetrance, neuropharmacokinetic profile, and mechanistic effect on tumor cell metabolism of PCZ in adults with GBM.

Click here to read journal article: Neurosurgery: October 2022 - Volume 91 - Issue 4 - p 658-665

Get Involved

Associated CNS Websites

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy

×